Skip to Content

Butrans Approval History

FDA Approved: Yes (First approved June 30, 2010)
Brand name: Butrans
Generic name: buprenorphine
Dosage form: Transdermal System
Company: Purdue Pharma L.P.
Treatment for: Pain

Butrans (buprenorphine) is a transdermal opioid analgesic for the management of moderate to severe chronic pain in patients requiring continuous treatment for an extended period of time.

Development History and FDA Approval Process for Butrans

DateArticle
Sep 24, 2013Approval Purdue Pharma L.P. Receives FDA Approval For 15 mcg/hour Dosage Strength Of Butrans (buprenorphine) Transdermal System CIII
Jul  1, 2010Approval Purdue Pharma L.P. Receives FDA Approval for Butrans (buprenorphine) Transdermal System CIII

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide